Sirna Therapeutics Funding: $84M Raised, Series B (2023)
Sirna Therapeutics is based in Boulder, Colorado. It has raised $84M in total funding. Latest round: Series B.
Sirna Therapeutics funding overview
Sirna Therapeutics is based in Boulder, Colorado. Sirna Therapeutics has raised $84M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2023. The round record for Sirna Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Black Point Group, GeneChem, Merck & Co., Morgenthaler Ventures, New Leaf Venture. 5 distinct backers are named across the disclosed rounds.
Sirna Therapeutics at a glance
Total raised
$84M
Latest round
Series B
Latest round date
October 2023
Headquarters
Boulder, Colorado
Notable investors
Black Point Group, GeneChem, Merck & Co., Morgenthaler Ventures, New Leaf Venture
Frequently asked about Sirna Therapeutics funding
How much has Sirna Therapeutics raised?
Sirna Therapeutics has raised $84M in total disclosed funding across the rounds on record.
Who has invested in Sirna Therapeutics?
Black Point Group, GeneChem, Merck & Co., Morgenthaler Ventures, New Leaf Venture are named among the investors backing Sirna Therapeutics.
What was the latest Sirna Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2023.
Where is Sirna Therapeutics based?
Sirna Therapeutics is based in Boulder, Colorado.
When did Sirna Therapeutics last raise?
The last disclosed Sirna Therapeutics round closed in October 2023 at Series B.
Round data for Sirna Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boulder and backer lists below.
